Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Letter to the Editor

Comments on Fouchier's Calculation of Risk and Elapsed Time for Escape of a Laboratory-Acquired Infection from His Laboratory

Lynn C. Klotz
Lynn C. Klotz
Center for Arms Control and Non-proliferation, Washington, DC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.00268-15
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

In a Letter to the Editor of mBio, Professor Ron Fouchier published a calculation (1) in which he finds a very low probability, P1, for a laboratory-acquired infection (LAI) for a single lab for a single year. Claiming numerous safety precautions in his biosafety level 3 (BSL3+) laboratory, Fouchier calculates P1 = 1 × 10–7 per person per year, and since there are 10 workers with access to his laboratory, P1 = 1 × 10–6 per lab per year. Compare this to P1 = 2 × 10–3 per lab per year for BSL3 laboratories calculated from CDC statistics for undetected or unreported LAIs (2, 3), here called “community LAIs,” as it is assumed that an undetected or unreported LAI represents an infection that has traveled outside the lab and into the community.

Recently reported escapes of LAIs from high-level biocontainment at CDC laboratories (4) and the long history of LAIs and other escapes from laboratories (5) also argue that Fouchier's value for P1 is too low. Lipsitch and Inglesby (6) have supplied additional arguments as to why the Fouchier value for P1 is likely much too low.

Fouchier uses a simplistic formula, y = 1/P1, to calculate the elapsed time in years for an LAI to escape from his laboratory, y = 1/(1 × 10–6) = 1 × 106, that is, the million years stated in his Letter. It is not clear what this calculation tells us. Does it give us the elapsed time for a 10% chance that an LAI occurs? Does it give us elapsed time for a 50% chance, or an 80% chance? In this regard, the elapsed time for a 100% chance is infinite, as we can never be absolutely certain that an LAI will occur.

I suggest attaching little weight to this elapsed time calculation and instead concentrating on risk = likelihood × consequences, starting with the P1 probability, specifically: potential pandemic fatalities = (probability of a community LAI) × (probability that the community LAI leads to a pandemic) × (estimated fatalities in a pandemic).

My risk calculation estimates the likelihood of a community LAI for both a single laboratory and n laboratories conducting this research over y years. The total number of laboratories involved in this potential pandemic pathogen research is called here the “research enterprise.”

A single, easily derived equation is used to determine the likelihood of a community LAI: E=1−(1−P1)yn(1) where E is the probability of at least one community LAI from n laboratories in y years. Example results are presented in Table 1 for three values of P1.

View this table:
  • View inline
  • View popup
TABLE 1 

Probabilities of at least one LAI escape into the communityc

In Table 1, the number of laboratories is either n = 1 for a single laboratory, such as Fouchier's, or n = 30, which is twice the 15 laboratories currently subject to the NIH funding pause. Picking n = 30 is a reasonable guess since there are likely many other labs throughout the world conducting this research that are not funded by NIH. y = 10 years is a reasonable time frame for this research to be completed.

The rationale for picking the probabilities, P1, in Table 1 is as follows: P1 = 2 × 10–3 is calculated from the CDC statistics (2, 3). P1 = 2 × 10–4 is 10-fold less and is my “guestimate” for a BSL3+ lab with rigorous safety practices. P1 = 1 × 10–6 is Fouchier's calculated value.

There are valuable observations to be gleaned from Table 1. For instance, taking into account the whole research enterprise, not just a single lab, is important.

Furthermore, even for Fouchier's very low value for P1, there is an estimated probability of E = 0.0003 that there will be at least one community LAI over a 10-year period for 30 labs (likely exactly one LAI, as two is much less probable). As I will soon show, E = 0.0003, or 0.03%, is not nearly small enough to reduce risk to an acceptable level. Also, this E value assumes that all 30 laboratories involved in this research enterprise have the rigorous safety practices of Fouchier's lab, a highly unlikely assumption.

Summarizing the literature, Lipsitch and Inglesby (7) estimate the probability that a community LAI leads to a global spread (pandemic) to be 5 to 60%. This range is consistent with the 5 to 15% range found by Merler and coworkers (8) and with the 1 to 30% range found in a focused risk assessment (9) for infection spread beginning on crowded public transportation. As an illustration, using an intermediate value of 10% for pandemic probability, which is within the estimated ranges, the probability that a community LAI occurs and leads to a pandemic would be 0.0003 × 0.1 = 3 × 10–5.

A pandemic could result in 140 million fatalities (world population of 7 billion, 20% infected, 10% fatality rate). Thus, in this example the estimated number of fatalities for the research enterprise could be 3 × 10–5 × 140 million = 4,200 fatalities, and the estimated “fatality burden” for each lab in the research enterprise could be 4,200/30 = 140 fatalities over 10 years or 14 fatalities per year. To put this fatality burden number in perspective, no Institutional Review Board tasked with assessing human subject research would approve a proposed research project with 14 potential fatalities per year.

If instead P1 = 2 × 10–4 or P1 = 2 × 10–3 is more representative of the real probability, then the fatalities and fatality burden for each lab in the enterprise would be much higher. Over the assortment of BSL3 and BSL3+ labs that may be participating in the research enterprise, frighteningly high fatality burdens may not be unrealistic.

To try to understand the meaning of Fouchier's simplistic equation y = 1/P1, I substitute into equation 1 the values calculated by Fouchier (P1 = 1 × 10–6, y = 1 × 106 years, n = 1, for his single lab) to find E = 0.63. As I suspected, the value is high. While I do not know of anything significant that we might learn from this observation that Fouchier's calculation implicitly implies a high value for E, it at least answers the question put forth in the second paragraph of this letter about the meaning of his calculation of elapsed time to an escape. Recall that the highest value of the probability E is 1.0, which implies absolute certainty of an escape, which would take infinite elapsed time, y.

Even if every laboratory in the research enterprise is as safe as Fouchier claims his is, potential pandemic fatalities and fatality burden are still too great. Until the research enterprise is restricted to only a few special BSL4+ labs, with extraordinary precautions (3) to reduce significantly the probability of community infections, the international community should agree to pause this research indefinitely. Alternatively, the research should be redesigned to not require the development of live respiratory aerosol-transmissible potential pandemic pathogens (10).

  • Copyright © 2015 Klotz.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

REFERENCES

  1. 1.↵
    1. Fouchier RA
    . 2015. Studies on influenza virus transmission between ferrets: the public health risks revisited. mBio 6(1):e02560-14. doi:10.1128/mBio.02560-14.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Henkel RD,
    2. Miller T,
    3. Weyant RS
    . 2012. Monitoring select agent theft, loss and release reports in the United States—2004–2010. Appl Biosafety 18:171–180. http://www.absa.org/abj/abj/121704FAHenkel.pdf.
    OpenUrl
  3. 3.↵
    1. Klotz LC,
    2. Sylvester EJ
    . 2014. The consequences of a lab escape of a potential pandemic pathogen. Front. Public Health 2:116. doi:10.3389/fpubh.2014.00116.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Sun LH,
    2. Achenbach J
    . 2014. CDC reports potential Ebola exposure in Atlanta lab. Washington Post, Washington, DC. http://www.washingtonpost.com/national/health-science/cdc-reports-potential-ebola-exposure-in-atlanta-lab/2014/12/24/f1a9f26c-8b8e-11e4-8ff4-fb93129c9c8b_story.html?wpisrc=al_national.
  5. 5.↵
    1. Furmanski M
    . 2014. Lab escapes and “self-fulfilling prophecy” epidemics. Center for Arms Control and Nonproliferation, Washington, DC. http://armscontrolcenter.org/Escaped_Viruses-final_2-17-14.pdf.
  6. 6.↵
    1. Lipsitch M,
    2. Inglesby TV
    . 2015. Reply to “studies on influenza virus transmission between ferrets: the public health risks revisited.” mBio 6(1):e00041-15. doi:10.1128/mBio.00041-15.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Lipsitch M,
    2. Inglesby TV
    . 2014. Moratorium on research intended to create novel potential pandemic pathogens. mBio 5(6):e02366-14. doi:10.1128/mBio.02366-14.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Merler S,
    2. Ajelli M,
    3. Fumanelli L,
    4. Vespignani A
    . 2013. Containing the accidental lab escape of potential pandemic influenza viruses. BMC Med 11:252. doi:10.1186/1741-7015-11-252.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Klotz LC
    . 2014. The human fatality and economic burden of a man-made influenza pandemic: a risk assessment. Center for Arms Control and Non-Proliferation, Washington, DC. http://armscontrolcenter.org/The_Human_Fatality_Burden_of_Gain_of_Function_Flu_Research_v1-5-14.pdf.
  10. 10.↵
    1. Lipsitch M,
    2. Galvani AP
    . 2014. Ethical alternatives to experiments with novel potential pandemic pathogens. PLoS Med 11:e1001646. doi:10.1371/journal.pmed.1001646.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Comments on Fouchier's Calculation of Risk and Elapsed Time for Escape of a Laboratory-Acquired Infection from His Laboratory
Lynn C. Klotz
mBio Apr 2015, 6 (2) e00268-15; DOI: 10.1128/mBio.00268-15

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Comments on Fouchier's Calculation of Risk and Elapsed Time for Escape of a Laboratory-Acquired Infection from His Laboratory
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Comments on Fouchier's Calculation of Risk and Elapsed Time for Escape of a Laboratory-Acquired Infection from His Laboratory
Lynn C. Klotz
mBio Apr 2015, 6 (2) e00268-15; DOI: 10.1128/mBio.00268-15
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511